Summary
- Current Price
- As of today, FDMT price is $9.33, down -8.35% on
- Current Price All-Time High
- FDMT price is currently -83.07% below its historical high of $55.11 set on
- Market Cap
- FDMT current market cap is $533M, up +223.39% over the past 365 days
- PE Ratio
- FDMT PE ratio is unknown
- Revenue
- FDMT current annual revenue is $85.21M, up +230194.59% year-over-year
- Next Earnings
- The next earnings release for FDMT is on
Profile
| Metric | Value |
|---|---|
| Full Name | 4D Molecular Therapeutics, Inc. |
| Ticker | NASDAQ: FDMT |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | 4dmoleculartherapeutics.com |
| Employees | 227 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $9.33 | |
| Price, 1D Change | -8.35% | |
| $533M | ||
| - | ||
| - | ||
| 1.28 | ||
| $85M | ||
| Revenue, 1Y Change | +230,194.59% | |
| -$2.42 | ||
| EPS, 1Y Change | +18.90% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$2.42 | ||
| EPS Estimate | N/A | -$3.81 |
| EPS Est. Change | N/A | -57.43% |
| $85.21M | ||
| Revenue Estimate | N/A | $8.89M |
| Revenue Est. Change | N/A | -89.57% |
| Current Price | $9.33 | |
| Price Target | - | $33.00 |
| Price Tgt. Change | - | +253.70% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.92 | -$2.98 | -1.97% | |
| -$3.26 | -$2.42 | +25.78% | |
| -$3.81 | N/A | -57.43% | |
| -$3.80 | N/A | -56.94% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.38M | $37.00K | -97.33% | |
| $37.74M | $85.21M | +125.76% | |
| $8.89M | N/A | -89.57% | |
| $14.83M | N/A | -82.59% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $9.33 | |
| $7.99 | ||
| SMA 200 vs Price | -14.35% | |
| $8.89 | ||
| SMA 50 vs Price | -4.72% | |
| 1.28 | ||
| $0.69 | ||
| 53.17 | ||
| 78.60% | ||
| 97.53% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $85.21M | ||
| -$2.42 | ||
| $77.58M | ||
| 91.05% | ||
| -$159.55M | ||
| -187.24% | ||
| -$140.11M | ||
| -164.43% | ||
| -$151.92M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.04 | ||
| 9.39 | ||
| 9.39 | ||
| - | ||
| 4 | ||
| 3.47 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 6.26 | ||
| 1.05 | ||
| -1.00 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $505.66M | ||
| $402.66M | ||
| $566.71M | ||
| $413.13M | ||
| $61.05M | ||
| $43.99M | ||
| $21.41M | ||
| $5.59M | ||
| $11.16M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $225.32M | ||
| $237.13M | ||
| $7.63M | ||
| $0.00 | ||
| $7.63M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$109.08M | ||
| -$92.97M | ||
| $112.96M | ||
| $536.00K | ||
| -$109.62M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| RBC Capital | → | |
| Chardan Capital | → | |
| Barclays | ||
| Chardan Capital | → | |
| RBC Capital | → | |
| Chardan Capital | → | |
| Barclays | → | |
| RBC Capital | → | |
| Roth Capital | → |
Analyst sentiment
Institutional ownership
Screeners with FDMT
FAQ
What is the ticker symbol for 4D Molecular Therapeutics, Inc.?
The ticker symbol for 4D Molecular Therapeutics, Inc. is NASDAQ:FDMT
Does 4D Molecular Therapeutics, Inc. pay dividends?
No, 4D Molecular Therapeutics, Inc. does not pay dividends
What sector is 4D Molecular Therapeutics, Inc. in?
4D Molecular Therapeutics, Inc. is in the Healthcare sector
What industry is 4D Molecular Therapeutics, Inc. in?
4D Molecular Therapeutics, Inc. is in the Biotechnology industry
What country is 4D Molecular Therapeutics, Inc. based in?
4D Molecular Therapeutics, Inc. is headquartered in United States
When did 4D Molecular Therapeutics, Inc. go public?
4D Molecular Therapeutics, Inc. initial public offering (IPO) was on December 11, 2020
Is 4D Molecular Therapeutics, Inc. in the S&P 500?
No, 4D Molecular Therapeutics, Inc. is not included in the S&P 500 index
Is 4D Molecular Therapeutics, Inc. in the NASDAQ 100?
No, 4D Molecular Therapeutics, Inc. is not included in the NASDAQ 100 index
Is 4D Molecular Therapeutics, Inc. in the Dow Jones?
No, 4D Molecular Therapeutics, Inc. is not included in the Dow Jones index
When was 4D Molecular Therapeutics, Inc. last earnings report?
4D Molecular Therapeutics, Inc.'s most recent earnings report was on November 10, 2025
When does 4D Molecular Therapeutics, Inc. report earnings?
The next expected earnings date for 4D Molecular Therapeutics, Inc. is May 7, 2026
Data Sources & References
- FDMT Official Website www.4dmoleculartherapeutics.com
- FDMT Profile on Yahoo Finance finance.yahoo.com/quote/FDMT
- FDMT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/fdmt